July 1 (Reuters) - Bone Therapeutics SA BOTHE.BR :
* REG-BONE THERAPEUTICS SECURES UP TO €16 MILLION LOAN
FINANCING
FROM THE EUROPEAN INVESTMENT BANK TO ACCELERATE ONGOING CLINICAL
AND COMMERCIAL DEVELOPMENT OF INNOVATIVE ORTHOPEDIC TREATMENT
* EIB FINANCING TO BE USED FOR BONE THERAPEUTICS' ALLOGENEIC
CELL
THERAPY PLATFORM ALLOB AND POTENTIAL COMMERCIALIZATION OF
ENHANCED VISCOSUPPLEMENT JTA-004
* ON JTA-004: PLANS TO SUBMIT A MARKETING AUTHORIZATION
APPLICATION TO EUROPEAN REGULATORY AUTHORITIES IN FIRST HALF OF
2022
* ON ALLOB: PLANNED TOP LINE RESULTS ARE EXPECTED IN H2 2022
Source text for Eikon: ID:nGNE2Bk2Vv
Further company coverage: BOTHE.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))